Objective: To assess if arachnoid cells have the capability to present antigen and activate T-lymphocytes after stimulation by bloody cerebrospinal fluid (CSF), and to illuminate the mechanism of coagulation-initiated inflammation in the subarachnoid space after subarachnoid hemorrhage (SAH). Methods: Arachnoid cells were cultured, characterized, and examined by immunofluorescence for the basal expression of human leukocyte antigen-DR (HLA-DR). Expression of HLA-DR, after co-culturing arachnoid cells in vitro with bloody CSF, was investigated by immunofluorescence and flow cytometry (FCM). The variation of arachnoid cells' ultrastructure was observed by transmission electron microscope (TEM). Arachnoid cells were co-cultured with peripheral blood mononuclear cells (PBMCs). The content of soluble interleukin-2 receptor (sIL-2r) in culture medium was detected by enzyme-linked immunosorbent assay (ELISA). Results: (1) Arachnoid cells were successfully cultured for many passages. The immunofluorescent staining was positive for HLA-DR in over 95% of the human arachnoid cells. The punctate HLA-DR was distributed in cytoplasm and not in the karyon. (2) After co-culturing arachnoid cells in vitro with bloody CSF, numerous particles with strong fluorescence appeared in the cytoplasm on Day 6. On Day 8, the quantity of particles and fluorescent intensity were maximal. FCM showed that the percentage of HLA-DR expressing cells was (2.5±0.4)% at the first 5 d, increasing to (60.8±3.6)% on Day 7. (3) After co-culturing arachnoid cells in vitro with bloody CSF, many lysosome and secondary lysosome particles were present in the cytoplasm. Hyperplasia of rough endoplasmic reticulum and enlarged cysts were observed, with numerous phagocytizing vesicles also observed at the edge of the arachnoid cells. (4) Arachnoid cells stimulated by bloody CSF were co-cultured in vitro with PBMCs. The content of sIL-2r in the culture medium, having been maintained at around 1.30 ng/ml during the first 3 d, had increased by Day 4. The content of sIL-2r peaked 7.53 ng/ml on Day 7 and then reduced gradually. Conclusions: (1) Basic HLA-DR expression is present in arachnoid cells. (2) After stimulation by bloody CSF, arachnoid cells have the potential to serve as antigen presenting cells (APCs) and the ability to activate T-lymphocytes, indicating that arachnoid cells are involved in the mechanism of coagulation-initiated inflammation in the subarachnoid space after SAH.
Introduction
Subarachnoid hemorrhage (SAH) is a frequent occurrence in cerebrovascular accidents, and cerebral vasospasm, especially delayed cerebral ischemia (DCI), is a serious complication after SAH (Kubota et al., 1993; Raymackers et al., 2000; Claassen et al., 2001; Gomis et al., 2005; Todo et al., 2008; Eddleman et al., 2009) . The aetiology and pathophysiology of SAH-related vasospasm remain controversial (Chrapusta et al., 2000; Wada et al., 2002; Hendryk et al., 2004; Aydin et al., 2005; Wang et al., 2005; Nekludov et al., 2007) . Some studies (Frank and Boyce, 1983; Akopov et al., 1992; Mathiesen et al., 1993; Massicotte and Del Bigio, 1999; Chrapusta et al., 2000; Ahn et al., 2002; Kim et al., 2002; Zubkov et al., 2002; Stein and Smith, 2004; Harrod et al., 2005) have shown that lymphocytes and macrophages are observed in the subarachnoid space during Days 2-5 after SAH. On Day 5, the quantities of T-lymphocytes and macrophages peak, and the proportion of CD4/CD8 is also increased. The activated mononuclear macrophages and lymphocytes secrete endothelin-1 and cytokines (e.g., interleukin-6 (IL-6), soluble interleukin-2 receptor (sIL-2r), tumor necrosis factor-α, adhesion molecules). Inflammation occurs in the subarachnoid space after SAH. The cerebral vasospasm after experimental SAH is prevented by lymphocyte-associated antigen-1 monoclonal antibody and humanized anti-CD11/ CD18 monoclonal antibody despite the unaltered presence of hemoglobin (Frank, 1995; Ogihara et al., 2001; Clatterbuck et al., 2002; Pradilla et al., 2004) . These data support the hypothesis that inflammation plays a role in cerebral vasospasm after SAH.
The coagulation/inflammation interface participates in a variety of disease processes, and the interactions between coagulation and inflammation are complex. Inflammation cytokines are the major mediators involved in coagulation activation (Sanchez et al., 2004; Esmon, 2005; Muth et al., 2005; Recinos et al., 2006) . In addition, the tissue factor-VIIa complex can induce pre-inflammatory effects on macrophage/monocyte, such as the expression of major histocompatibility complex (MHC) class II molecules (Motohashi et al., 1995b; Chrapusta et al., 1999) . It is still unknown whether arachnoid cells are involved in the interactions between coagulation and inflammation in the subarachnoid space after SAH.
In the present study, arachnoid cells were co-cultured with bloody cerebrospinal fluid (CSF) and peripheral blood mononuclear cells (PBMCs) to simulate the microenvironment of the subarachnoid space after SAH. In addition to assessing if arachnoid cells have the capability to present antigen and activate T-lymphocytes after stimulation by CSF, it was the further aim of our study to preliminarily illuminate the mechanism of coagulation-initiated inflammation in the subarachnoid space after SAH.
Materials and methods

Culture and passage of human arachnoid cells
Under the operating microscope, we cut off the human arachnoid membranes which were transparent, colourless, and without adhesions. The membranes were cut into ≤1 mm 3 sections. These sections were plated in 25-cm 2 Falcon flasks with complete medium (Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% (v/v) fetal bovine serum, 100 U/ml penicillin, 100 U/ml streptomycin, and 0.1 mU/ml insulin). The flasks were maintained at 37 °C in a 95% humidity incubator with 5% CO 2 atmosphere. The medium was added into the flask 24 h later and changed every 3 to 4 d. Arachnoid cells were passaged on Days 20-24 from the bottom of the flask. After the medium was removed, the arachnoid cells were washed twice in Hanks' buffer and digested in 1:1 (v/v) dilution with 0.25% (w/v) trypsin and 0.02% (w/v) ethylenediamine tetra-acetic acid (EDTA) at room temperature for 8-10 min. The complete medium was added to stop the digestion, with an arachnoid cell suspension concentration of 4×10 5 cells/ml. The cell suspension was used for serial subcultivation. The arachnoid cells were passaged two to three times prior to testing.
Expression of cytokeratin 8&18 and HLA-DR in arachnoid cells by immunofluorescence staining assay
The passaged cells were fixed on coverslips in acetone-methanol (1:1, v/v) solution and then rinsed by 0.01 mol/L phosphate buffered saline (PBS). A total of 200 μl deactivated rabbit serum (1:20 (v/v) dilution) was used to block Fc receptor at 4 °C for 3 h. Arachnoid cells were stained for immunofluorescence. The primary antibody, monoclonal mouse anticytokeratin 8&18, was used at a 1:100 (v/v) dilution and the monoclonal mouse anti-human leukocyte antigen-DR (HLA-DR) was used at a 1:200 (v/v) dilution. The secondary antibody, fluoresceinconjugated goat anti-rabbit immunoglobulin G (IgG; Sigma, USA) was used at a 1:100 (v/v) dilution. The preparation was examined with fluorescence microscopy (Olympus BX50, Olympus Co., Tokyo, Japan) and photographed with Kodak film (Eastman Kodak Co., NY, USA).
Investigation of variation of HLA-DR expression of arachnoid cells co-cultured with bloody CSF by immunofluorescence and flow cytometry
Arachnoid cells were grown on coverslips in each well of the culture plate. We obtained the bloody CSF from patients 3 d after spontaneous SAH by lumbar puncture and maintained it at 4 °C. We diluted the bloody CSF by serum-free medium, keeping the number of red blood cells at 20 000 cells/ml, and 0.3 ml of this CSF was added with each change of the medium. The cells of three independent wells were examined daily for 12 d.
Arachnoid cells were collected as scheduled. These cells were placed into cell suspension. Cell concentration was adjusted to 5×10 6 -1×10 7 cells/ml.
A total of 40 μl of cell suspension was placed into a centrifuge tube with 2 µg of monoclonal mouse anti-human HLA-DR. In addition, 2 µg of control murine antibody with the same isotype was added to control samples. A total of 50 µl deactivation cony serum 1:20 (v/v) dilution by Dulbecco's phosphatebuffered saline (DPBS; NaCl 80 g, KCl 2 g, Na 2 HPO 4 11.5 g, KH 2 PO 4 2 g, distilled water 1000 ml, 1:10 (v/v) dilution when used) was added to every sample. These samples were maintained at 4 °C for 30 min. After being washed, 50 µl 1:250 (v/v) diluted fluorescein isothiocyanate (FITC)-conjugated goat antimouse IgG was added and shaken, washed twice with 1 ml fixation fluid (DPBS 1000 ml, glucose 20 g, formaldehyde 10 ml, NaN 3 0.2 g, final concentration 0.02% (w/v)) before examination by flow cytometry (FCM; Elite ESP Type, Coulter Co., California, USA).
Investigation of variation of ultrastructure of arachnoid cells co-cultured with bloody CSF by transmission electron microscope
Arachnoid cells were co-cultured with bloody CSF under the previously mentioned concentration for 7 d. Cells of the control sample were cultured without bloody CSF. They were digested into monoplast suspension, washed by 0.15 mol/L PBS, centrifuged into cell cakes, fixed by 2.5% (w/v) glutaral phosphate buffer, washed by cold cane sugar buffer, fixed by osmic acid, dehydrated by acetone, and then dipped in araldite for rigidification. These samples were made into extra-thin sections for examination by transmission electron microscope (TEM; JEM-2000EX, Jed, Japan) and photos. Grouping: control group 1 (CG1), arachnoid cells were co-cultured with PBMCs; control group 2 (CG2), PBMCs were cultured alone; experimental group (EG), arachnoid cells stimulated by bloody CSF were co-cultured with PBMCs.
Cultivation of cells: arachnoid cells were cultured in a 96-well plate at a concentration of 10 2 cells/well. CG1: 100 µl PBMC suspension (about 1×10 5 cells/ml) was added into every well. EG: 0.3 ml bloody CSF with same concentration was added for stimulation for 3 d. This suspension was removed from the bloody CSF and co-cultured with PBMCs for 9 d. The supernatant of the culture was collected on Days 1-9 with the duplicates. Human sIL-2r enzyme-linked immunosorbent assay (ELISA) kit (Antigenix, USA) and ELISA detector (Model 550, Bio-Rad Company, USA) were used in the examination of sIL-2r content of supernatant. Mean and standard deviation (SD) of every four optical density (OD) values at different times were calculated and compared with standard curve for sIL-2r content.
The statistical work-up was performed by using SPSS 11.0 computer programme to compare CG1 and CG2 with EG. The confidence interval and significance level were set at be 95% and P<0.05, respectively.
Results
Appearance of cultured arachnoid cells
The cells formed a monolayer (Fig. 1) and were polygonal in shape. The cells had larger nuclei and had one to two nucleoli each. Many granules existed in the cytoplasm. The cells were compact and had good refraction. The appearance of the cells was some similar to epithelium. Cell proliferation increased during Days 8-15. After six to eight passages, cell growth declined.
Ultrastructure of cultured arachnoid cells
Keratin was uniformly distributed in the cytoplasm. A moderate quantity of rough endoplasmic reticula and chondriosomes were seen. Affluent Golgi bodies, ribosomes, and small quantities of cytolysis were also observed. Secretory granules existed in a few cells. The cystoskeleton was made up of intermediate filament and microfilament. The structure of cells was somewhat similar to epithelium.
Cytokeratin 8&18 and HLA-DR expression of cultured arachnoid cells
Cytokeratin 8&18 was expressed by the majority of cells (over 95%). They were silky and distributed in cytoplasm, but not in the karyons. HLA-DR was also basally expressed by the majority of cells (over 95%). They were punctiformly distributed in cytoplasm, but not in the karyons.
Immunofluorescence detection on variation of HLA-DR expression of cultured arachnoid cells after being stimulated by bloody CSF
From 1-120 h, the expression of HLA-DR had no obvious variation. By Day 6, many particles with strong fluorescence had begun to appear in the cytoplasm, mostly around the karyon. On Day 8, the quantity of the particles and their fluorescent intensity were at the vertex (Fig. 2) . Thereafter, the fluorescent intensity became weak and fluorescent granules decreased.
FCM detection on variation of HLA-DR expression of cultured arachnoid cells after stimulation by bloody CSF
After stimulation by bloody CSF, the percentage of HLA-DR expressing cells remained at (2.5±0.4)% (n=3) for 1-120 h. On Day 6, the percentage increased to (9.2±1.2)%. On Day 7, the percentage increased to (60.8±3.6)% (Fig. 3) , and then began to decrease. On Day 10, it was (12.5±2.5)%. The variation detected by FCM coincided in time with that of immunofluorescence.
TEM detection on variation of arachnoid cells' ultrastructure after stimulation by bloody CSF
On Day 7, lysosomes and secondary lysosomes were greatly increased in number. Hyperplasia of rough endoplasmic reticulum and an enlarged cyst pool were observed. Many pinocytosis bubbles were observed at the edge of cells. Some bubbles were observed in the endocytic process (Fig. 4) . 
ELISA detection on variation of sIL-2r content in the culture supernatant
The sIL-2r contents in the culture supernatants of CG1 and CG2 were unchanged with time-lapse and were about 1.40 ng/ml, but it appeared different when arachnoid cells stimulated by bloody CSF were co-cultured with PBMCs. During Days 1-3, the sIL-2r content was around 1.30 ng/ml. On Day 4, the sIL-2r content increased to 2.57 ng/ml. On Day 6, the sIL-2r increased to 6.86 ng/ml. On Day 7, it peaked to 7.53 ng/ml. On Day 8, the content began to decrease. On Day 9, it was 5.30 ng/ml (Table 1 , P<0.01, comparison of CG1 and CG2 with EG, respectively, from Day 4 to Day 9).
Discussion
The arachnoid membrane has been considered to be no more than a layer of connective tissue. Research shows, however, that arachnoid cells phagocytize foreign matter, express HLA-DR antigen, IgG receptor, and complement receotor, and have antigen presenting cell (APC)-like characteristics and activities (Frank, 1995; Bernstein et al., 1996; Prignano, 1998; McMenamin et al., 2003) . Arachnoid cells can secrete many cytokines, e.g., fibroblast growth factor (FGF) and transforming growth factor-β (TGF-β), and express glial fibrillary acidic proteins, the idio-proteins of gliocytes (Mathiesen and Lefvert, 1996) . There are 18 kinds of CSF proteins secreted by cells of cultured leptomeninges (Raymackers et al., 2000) . Thus, arachnoid cells may participate in antigen presentation in the subarachnoid space. SAH can induce proliferation of leptomeningeal cells (McMenamin, 1999) .
Cytokeratin, a kind of keratin, is a molecular marker of epithelial differentiation. It is used to investigate the differentiation and function of epithelium and identify arachnoid cells (Murphy et al., 1991; Frank, 1995) . In our research, arachnoid cells formed a monolayer and were polygonal in shape. The cells had large nuclei and many cytoplasmic granules. Approximately 95% of arachnoid cells expressed cytokeratin, in agreement with previous studies (Murphy et al., 1991; Frank, 1995) .
It is known that T cells cannot discriminate the determinant groups of native protein antigen and need the presentation of APCs. MHC-I and MHC-II are considered to be the carriers of antigen polypeptides. HLA-DR is one kind of MHC-II and is primarily expressed on APCs (e.g., macrophages, B lymphocytes, dendritic cells, monocytes, activated T cells, Langhans' cells, and spermatozoons). Cells which can express HLA-DR are considered to be functional APCs. The level of expression is related to activation stimulation by antigen.
Our research shows that, after being stimulated by bloody CSF, the HLA-DR expression of arachnoid cells increased, and the results of immunofluorescence and FCM were temporally consistent. On Day 6, the expression of HLA-DR began to increase. On Day 7, the expression significantly increased. The hemolyses of red blood cells (RBCs) and other cells are endogenous antigens which may be presented to arachnoid cells. Arachnoid cells phagocytize and elaborate these antigens and combine the antigen determinants with HLA-DR. Time is needed to express the combination of antigen-polypeptide-HLA-DR on the surface of arachnoid cells. In the first 5 d, the expression is maintained at basal level. On Day 6, the combination is expressed on the cell surface and can be detected by FCM. The morphologic appearance is that of activation. The increase of lysosomes, endoplasmic reticulum, and enlargement of the cyst-pool are evidence indicating that cells phagocytize and elaborate antigens and synthetize proteins (e.g., the lysosomal hydratase and HLA-DR molecule). Increased pinocytosis bubbles were also observed in the cells. These morphologic variations indicate that arachnoid cells have macrophage-like characteristics and activation capabilities.
IL-2r exists in two forms: membrane IL-2r (mIL-2r) and sIL-2r. After synthesis, sIL-2r falls from the cellular membrane into blood or culture supernatant. In this study the content of sIL-2r was measured to reflect the activation degree of T-lymphocytes (Jackowski et al., 1990) . After being stimulated by bloody CSF, arachnoid cells were co-cultured with PBMCs. The content of sIL-2r in the supernatant began to rise from Day 4, indicating that the MHC-antigen combination provides activation signals to T cells acting with T-lymphocyte receptor (TCR). Activated T lymphocytes express IL-2r, which can then be detected. On Day 7, sIL-2r content arrived at the vertex, indicating T cell activation.
CG1 and CG2 showed cultured PBMCs alone or with arachnoid cells, and the content of sIL-2r in supernatant was maintained at a basal level because MHC-antigen combination was not presented on unstimulated arachnoid cells. These results indicate that not only the origin of bloody CSF but also the white cells in the bloody CSF confound the issue. Arachnoid cells and PBMCs in our research were obtained from single patient, thus avoiding lymphocyte antigen activation.
The mechanism of coagulation-initiated inflammation has not been fully illuminated. Thrombin is a multifunctional enzyme which generates procoagulant, anticoagulant, inflammatory, and mitogenic responses (Sanchez et al., 2004; Esmon, 2005; Muth et al., 2005; Recinos et al., 2006) . Platelet activation also appears to contribute to the inflammatory response (Kwon and Jeon, 2001; André et al., 2002; Esmon, 2005) . The tissue factor-VIIa complex can induce preinflammatory effects on the macrophage/ monocyte, such as the expression of MHC-II molecules (Motohashi et al., 1995b; Chrapusta et al., 1999) . Thrombin, TGF-β, and granulocyte-macrophage colony-stimulating factor can promote leptomeninggeal cell proliferation (Motohashi et al., 1995a; Takizawa et al., 2001; Jin et al., 2006) . Additionally, clinical DCI usually happens on Day 3, peaks 1-2 weeks after SAH, and then subsides gradually (Claassen et al., 2001; Todo et al., 2008; Eddleman et al., 2009) . The results of the present study are consistent with the time of DCI. Early on Day 2 post-SAH, a dramatic increase in the number of subarachnoid macrophages arose from a transformation of cells of the pia-arachnoid. This period was characterized by intense phagocytic activity, erythrocytes, fibrin, and other debris being largely cleared over the next 24 h. At 5 d post-SAH, the subarachnoid macrophage population declined, cells losing their mobile active features to assume a more typical pia-arachnoid cell appearance once more (Iuliano et al., 2004; Lan et al., 2005) .
Conclusions
After stimulation by bloody CSF, arachnoid cells have APC-like functions and mediate the immune reactions, this research indicating for the first time that arachnoid cells are probably involved in the interactions between coagulation and inflammation in subarachnoid space after SAH. 
